Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus

Author： Treadway J.L.   Mendys P.   Hoover D.J.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.3, 2001-03, pp. : 439-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Glycogen Phosphorylase in the Context of Type 2 Diabetes, with Focus on Recent Inhibitors Bound at the Active Site

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 12, 2010-10 ,pp. : 1102-1126

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Phosphorylase as a Target for Type 2 Diabetes: Synthetic, Biochemical, Structural and Computational Evaluation of Novel N-acyl-N´-(&bgr;-D-glucopyranosyl) Urea Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 23, 2015-01 ,pp. : 2373-2389

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment

By Eldar-Finkelman Hagit   Ilouz Ronit  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1511-1519

Informa Healthcare

Access to resources Recommend Favorite

Glycogen Phosphorylase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 845-857

Bentham Science Publishers

Access to resources Recommend Favorite

Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus

By Keating G.M.   Jarvis B.  

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2107-2119

Adis International

Access to resources Recommend Favorite